Dividend-adjusted total return · S&P 500 uses VOO · Aug 7, 2026 – Nov 5, 2026THNRS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −2.7% | +4.2% | −2.6% | +2.1% | +13.0% | — | — | +4.0% |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $6M
- Expense ratio
- 0.59%
- Distribution yield
- 1.6%
- NAV
- $26.37
- Volume
- 414
- Avg. volume 30D
- 826
- High today
- $26.27
- Low today
- $25.74
- Previous close
- $26.46
- 52-week high
- $27.94
- 52-week low
- $23.15
- Our risk indicator
- 4/5
THNR in One Breath
THNR Among Its Peers
YTDEnd-of-day Nov 5, 2026 · 1 ETFs by YTD
$10,000 in THNR
5Y$10,000 in THNR became
$10,396
In the S&P 500 (VOO)
$14,228
Total return, dividends in · May 21, 2024 – Nov 5, 2026 · S&P 500 uses VOO
THNR’s Top Holdings
TodayLLYEli Lilly &11.8%NVO8.9%AMGN6.2%AZN5.9%REGN5.8%GILD5.8%ROP.SW5.6%ABBV5.6%PFE5.5%MRK5.0%4519.T5.0%1093.HK4.6%1801.HK4.3%VKTX4.2%ARWR3.6%ZEAL.CO3.3%128940.KS2.9%1276.HK2.3%GPCR2.0%KLRA1.1%AGPXXOther
LLYEli Lilly &11.8%NVO8.9%AMGN6.2%AZN5.9%REGN5.8%GILD5.8%ROP.SW5.6%ABBV5.6%PFE5.5%MRK5.0%4519.T5.0%1093.HK4.6%8 more
Drug Manufacturers - GeneralBiotechnologyDrug Manufacturers - SpecialtyAsset Management
Amplify THNR · 20 holdings · tile size = share of the fund · as of Nov 5, 2026
What THNR Holds
TodayDrug Manufacturers - General69.9%
LLY 11.8 · NVO 8.9 · AMGN 6.2 · AZN 5.9 · GILD 5.8 · ROP.SW 5.6 · ABBV 5.6
Biotechnology24.3%
REGN 5.8 · 1801.HK 4.3 · VKTX 4.2 · ARWR 3.6 · ZEAL.CO 3.3 · GPCR 2.0 · KLRA 1.1
Drug Manufacturers - Specialty & Generic5.2%
128940.KS 2.9 · 1276.HK 2.3
Asset Management0.2%
AGPXX
Amplify THNR · share of the fund by industry · as of Nov 5, 2026
Eli’s Share of THNR
Today11.8%
$118 of every $1,000 in THNR is Eli
Eli held by THNR
$714K
Amplify THNR · each square = $10 of $1,000 · as of Nov 5, 2026
THNR’s Size vs Its Peers
Today$6.1Mthe largest ETF
AUM · THNR and the 0 largest peers · Nov 5, 2026
THNR Fee per $100 vs Peers
TodayExpense ratio · peers · Nov 5, 2026
Inside THNR
20 holdings · as of Nov 5, 2026THNR
Amplify Weight Loss Drug & Treatment ETF
TodayDrug Manufacturers - General69.9%LLYEli Lilly &11.8%NVO8.9%AMGN6.2%AZN5.9%GILD5.8%ROP.SW5.6%ABBV5.6%PFE5.5%MRK5.0%4519.T5.0%1093.HK4.6%Biotechnology24.3%REGN5.8%1801.HK4.3%VKTX4.2%ARWR3.6%ZEAL.CO3.3%GPCR2.0%KLRADrug Manufacturers - Specialty5.2%
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 11.76% |
| 2 | NVO | Novo Nordisk A/S | 8.92% |
| 3 | AMGN | Amgen | 6.21% |
| 4 | AZN | AstraZeneca | 5.88% |
| 5 | REGN | Regeneron Pharmaceuticals | 5.83% |
| 6 | GILD | Gilead Sciences | 5.82% |
| 7 | ROP.SW | Roche AG | 5.64% |
| 8 | ABBV | AbbVie | 5.59% |
| 9 | PFE | Pfizer | 5.53% |
| 10 | MRK | Merck & | 5.02% |
Drug Manufacturers - GeneralBiotechnologyDrug Manufacturers - SpecialtyAsset Management
Amplify THNR · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 99.4%
How It Compares
THNR
Amplify Weight Loss Drug & Treatment ETF’s Peers
YTDTHNR has no close peers in our data yet: […]
Similar peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
THNR vs VOO
YTDTHNR · Amplify Weight Loss Drug & Treatment
+2.1%
VOO · S&P 500
+8.4%
Gap
6.3 pts
Amplify THNR and Vanguard VOO · YTD total return · as of Nov 6, 2026
THNR vs Its Peer Average
YTDTHNRAvsBPeer average
1D−2.7%[…]
1M+4.2%[…]
3M−2.6%[…]
YTD+2.1%[…]
1Y+13.0%[…]
0–0level
0 peers · each row scaled to its leader
The Details
THNR
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y19.71%
Deepest drop · 1Y−13.9%
Lowest point · 5Y−21.2%
52-week range
$25.74
$23.15−7.9% from the high$27.94
Amplify THNR · past-year price moves · as of Nov 6, 2026
THNR
Fund Facts
Today2024launched May 21
Tracks[…]
Exchange · CUSIPAMEX · 032108532
StructureETF
Leverage1x
Cost on $10,000$59 a year
Go deeper
Amplify THNR · fund facts · as of Nov 6, 2026
THNR
Payouts by Year
2Y$0.41per share, Dec 2025
Distribution yield1.6%
Paid[…]
Latest ex-date · paidDec 30 · Dec 31, 2025
2 payouts added up$0.63 a share
Amplify THNR · distributions by ex-date · 2024–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Trading & Liquidity
Net asset value$26.37
Premium / discount[…]
Median spread · 30D[…]
Volume today414
Average volume · 30D826
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.59%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$59.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Dec 31, 2025 | $0.41 |
| Dec 30, 2024 | Dec 31, 2024 | $0.22 |
Issuer contentFrom AmplifyHear the strategy from the people behind THNR.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →